Salute e Benessere

Acclaro Medical Announces Opening of New Headquarters in Munich, Germany

An important player in the aesthetic laser business since 2018, Acclaro is enthusiastic and prepared to leverage the full potential of its UltraClear fiber laser with new and existing partners in the European Union. According to Reiner Kuchenbaur, Managing Director of Acclaro Medical GmbH, a wholly owned subsidiary of Acclaro Corporation, "the establishment of new corporate headquarters in Munich is a key progressive strategy that will help accelerate the exchange of clinical experiences…
PR Newswire
04/11/2024

Åsa Manelius Named Managing Director of Novavax AB Site

"Åsa brings deep global operations knowledge to Novavax during a critical time of transition for the Company," said Rick Crowley, Chief Operations Officer, Novavax. "As we focus on driving value via our proven technology platform through partnerships and R&D, Åsa and our AB site will be critical to ensuring robust supply of our best-in-class Matrix-M™ adjuvant for both our pipeline and potential partners." "Åsa brings deep global operations knowledge to Novavax…
PR Newswire
04/11/2024

Buyback of Class B shares in Essity during week 44, 2024

The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation. The share repurchase is financed using cash flow from current operations after the ordinary dividend with the ambition to continue with share buybacks over time as a recurring part of Essity's capital allocation. Class B shares in Essity were repurchased as follows: All purchases...
PR Newswire
04/11/2024

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT OCTOBER 2024

Accumulated revenue for January – October 2024 increased by 21 % to SEK 1691.7 (1402.4) million. Accumulated revenue for January –October 2024increased by 21 % toSEK 1691.7(1402.4) million. Revenues were distributed as follows: Countries in regions:-The Nordics:Denmark, Faroe Island,Finland,Iceland,Norway,Sweden- Central Europe :Austria,Germany,Switzerland- East Europe :Czech Republic,Slovakia,Hungary,Poland,Romania-South &West...
PR Newswire
04/11/2024

STAAR Surgical™ and Lucy Bronze, MBE See Eye to Eye on Vision Correction

Bronze has won five Champions League titles and has been one of her country's strongest performers since her senior team debut in 2013. Since then, she's won every domestic football honor in her country during spells with several teams, and she has also lived abroad to play for clubs in other countries. In addition, Bronze was named the 2018/19 UEFA Women's Player of the Year and The Best FIFA Women's Player for 2020. Bronze has won five Champions League titles and has been one of her…
PR Newswire
04/11/2024

Olon is ready to host productions in the new facility dedicated to ultra-potent…

“It is a new line that is highly advanced not only in terms of the technological level of its production facilities and design. But also, because it represents a real 'factory within a factory', with a warehouse area and a QC department. This will make it possible to handle highly active molecules in a straightforward and safer way, reducing the risks of contamination,” explains Marcello Buson, Head of Global Operations of the Olon Group.The area is also equipped with an HPLC preparation...
Nasdaq GlobeNewswire
04/11/2024

Trading by management and close relations of management

In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B. The released shares relate to the 2022 legacy Chr. Hansen restricted stock units (RSU) program.Please read the full announcement in PDF.
Nasdaq GlobeNewswire
04/11/2024

Smartee Strengthens Presence at 55th SIDO Congress in Florence

Italian orthodontists expressed enthusiasm for Smartee's comprehensive orthodontic solutions, catering to simple and complex cases. Dr. Antonio, Associate Professor at the University of Padua, shared, "I've recently started using Smartee GS products, which incorporate clear mandibular repositioning technology, and we're very pleased. It's a new product for us and quite different from what we've used in the past, especially in treating Class II malocclusions. So far, the results are…
PR Newswire
04/11/2024

OSE Immunotherapeutics Announces Statistically Significant and Clinically…

OSE Immunotherapeutics Announces Statistically Significant and Clinically Meaningful Results from the Phase 2 Study of Anti-IL7R mAb Lusvertikimab for the Treatment of Ulcerative Colitis Lusvertikimab met the primary endpoint (modified Mayo Score improvement) at each dose tested during the 10 week-induction period of treatment in the randomized double-blind CoTikiS Phase 2 study. Highly favorable positive results on the key secondary endpoints demonstrating significantly high rate of...
Nasdaq GlobeNewswire
04/11/2024

KFSHRC & Lilly Collaborate in Alzheimer's Early Detection

RIYADH, Saudi Arabia, Nov.03, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) and Eli Lilly Saudi Arabia signed an MoU today to improve Alzheimer's patient care. The Memorandum would pave the way to transform KFSHRC's Neuroscience Centre into a regional hub of excellence for Alzheimer's Disease.The Parties aim to jointly explore initiatives to educate and train Saudi Arabian healthcare professionals about neurodegenerative diseases such as...
Nasdaq GlobeNewswire
03/11/2024

Fashion and Textile Sectors Lead with Innovation at the 136th Canton Fair

Fashion sector presents new vision of innovative textile Fashion sector presents new vision of innovative textile Fujian Fashion Flying Garments Co., Ltd., is a leader in functional outdoor apparel. Their latest innovation, the Inflatable 3-in-1 Jacket with Amphibious Rescue Function, won the silver award at the Canton Fair Design Awards. This versatile jacket is ideal for outdoor activities like hiking and cycling, offering adjustable insulation and partial fastening to reduce...
PR Newswire
02/11/2024

Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the…

IMPACT-TD Registry, the largest study evaluating holistic effects of tardive dyskinesia (TD), highlights that there is a high burden of TD on quality of life regardless of a person's underlying mental health conditionRegistry revealed fewer patients with psychotic disorders (36%) received TD diagnoses compared to those with mood disorders (50%)Teva continues to further innovations in mental health and progress real-world data to improve treatment optimizationTEL AVIV, Israel and...
Nasdaq GlobeNewswire
01/11/2024

Tiziana Life Sciences to Participate in BIO-Europe 2024 to Discuss Recent…

The BIO-Europe conference provides a prestigious platform for Tiziana to highlight its strategic advancements to the biopharma community, as well as to expand its partnerships aimed at accelerating the development of its therapeutic pipeline. Key representatives from Tiziana will be available for discussions and will share data from our anti-CD3 and Ozempic combination study, which investigates the potential for enhanced therapeutic effects in targeted conditions. This latest clinical update...
Nasdaq GlobeNewswire
01/11/2024

WOLF's Ballet Musical Jewelry Box Selected as One of Oprah's Favorite Things…

LONDON, Nov. 1, 2024 /PRNewswire/ -- WOLF, the luxury brand synonymous with superior craftsmanship and elegant design, announced today that the Ballet Musical Jewelry Box has been included in Oprah's Favorite Things 2024 holiday gifts list, featured on OprahDaily.com and in Oprah Daily's special print 2024 Holiday Edition, on newsstands nationwide on November 12. LONDON , Nov. 1, 2024 /PRNewswire/ -- WOLF, the luxury brand synonymous with superior craftsmanship and elegant design,...
PR Newswire
01/11/2024

Latent TB Testing Market to Hit USD 773.4 Million by 2029 with 5.8% CAGR |…

Browse in-depth TOC on "Latent TB Testing Market" Browse in-depth TOC on "Latent TB Testing Market" 270 - Tables 46 - Figures 262 - Pages A significant technological shift which could redefine the business landscape in the latent TB testing market, is the growing interest in developing and refining IGRA tests. IGRA presents more significant advantages than tuberculin skin tests because these are more accurate and sensitive, especially for populations immunized with BCG…
PR Newswire
01/11/2024

Steam Trap Market worth $5.57 billion by 2029 - Exclusive Report by…

Browse in-depth TOC on "Steam Trap Market" Browse in-depth TOC on "Steam Trap Market" 160 – Tables 90 – Figures 250 – Pages Steam Trap Market Report Scope: Thermostatic segment is expected to exhibit highest CAGR in the steam trap market during the forecast period. Thermostatic steam traps are ruggedly designed and have a significantly long service life. They have fewer wear and tear than other types of steam traps, therefore keeping lower maintenance costs and reduced...
PR Newswire
01/11/2024

The 1-Year Follow-up Results of LuX-Valve Plus were Officially Released at TCT…

Safety results showed that the incidence of composite events remained low at 12.50%. Safety results showed that the incidence of composite events remained low at 12.50%. Efficacy results showed that TR grade, NYHA classification, and QoL improved significantly and continuously. At 1 year, Professor Juan F. Granada concluded that LuX-Valve Plus system is a versatile TTVR device that does not depend on radial force for anchoring. Its innovative design (ventricular septal anchor &...
PR Newswire
01/11/2024

Novo Nordisk A/S: Semaglutide 2.4 mg demonstrates superior improvement in both…

Bagsværd, Denmark, 1 November 2024– Novo Nordisk today announced the headline results from part 1 of the ongoing ESSENCE trial, a pivotal phase 3, 240-week, double-blinded trial in 1,200 adults with metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced liver fibrosis (stage 2 or 3) 1. Part 1 of the ESSENCE trial evaluated the effect of once-weekly semaglutide 2.4 mg on liver tissue (histology) compared to placebo on top of standard of care for the first 800...
Nasdaq GlobeNewswire
01/11/2024

Accord Healthcare unlocks £50m government fund to boost medicines manufacturing…

Accord is one of the UK's largest providers of medicines to patients and is proud to supply around 10% of the volume of all medicines to the NHS in the UK, around 200m packs a year, 75% of which are made in the UK. This new deal will enable Accord to be even more competitive with other countries in terms of manufacturing, thus helping to safeguard UK medicines supply during any future global public healthcare emergencies. Accord is one of the UK's largest providers of medicines to patients…
PR Newswire
01/11/2024

Orion Corporation: Managers' transactions – Henrik Stenqvist

ORION CORPORATIONMANAGERS' TRANSACTIONS1 NOVEMBER 2024 at 9.45 EET Orion Corporation: Managers' transactions – Henrik Stenqvist Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the notification...
Nasdaq GlobeNewswire
01/11/2024

National Comprehensive Cancer Network Joins with Vietnam National Cancer…

NCCN Chief Executive Officer Crystal S. Denlinger, MD will be presenting on the development and implementation of NCCN resources worldwide and in Vietnam, as part of an event hosted by Vietnam National Cancer Hospital (K Hospital)—Best of ASCO 2024: Multimodality Treatment of Cancer and Hospital Management in the Digital Era. During the conference, Dr. Denlinger will highlight the ongoing collaboration with the Vietnam National Cancer Hospital and the Vietnam Cancer Association to develop NCCN…
PR Newswire
01/11/2024

Pangea Laboratory Partners with Unilabs to Introduce Bladder CARE™ Assay in…

"Through this strategic partnership with Pangea Laboratory, Unilabs reinforces its commitment to driving innovation in diagnostics, bringing Bladder CARE™ to Switzerland as a next-generation solution that empowers early detection and advances patient care," said Patrick Bornand, Head of Pathology, Genetics & Oncology at Unilabs Switzerland. "Through this strategic partnership with Pangea Laboratory, Unilabs reinforces its commitment to driving innovation in diagnostics…
PR Newswire
01/11/2024

Eisai completes rolling BLA submission for subcutaneous maintenance dosing of…

AD is an ongoing neurotoxic process that begins before and continues after plaque deposition. Data suggest that early and continuing treatment may prolong the benefit even after plaque is cleared from the brain. This SC autoinjector is expected to be easier for patients and their care partners to use and may reduce the need for hospital visits and nursing care compared to IV administration. In addition to potentially maintaining the clinical and biomarker benefits, subcutaneous maintenance…
PR Newswire
01/11/2024

Global Dry Eye Disease Treatment Market Projected to Cross USD 9 Billion by 2030…

Key Takeaways from the Dry Eye Disease Treatment Market Report Key Takeaways from the Dry Eye Disease Treatment Market Report To read more about the latest highlights related to the dry eye disease treatment market, get a snapshot of the key highlights entailed in theGlobal Dry Eye Disease Treatment Market Report Dry Eye Disease Treatment Overview Dry eye disease (DED) is a multifactorial condition that results in chronic dryness, irritation, and inflammation of the ocular surface...
PR Newswire
31/10/2024
Altri  Comunicati